Migraine pathways and the identification of novel therapeutic targets

References

• Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211.
   PubMed Web of Science ®Google Scholar
• BK R, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12:221–228.
   PubMed Web of Science ®Google Scholar
• Russell MB, Ulrich V, Gervil M, et al. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache. 2002;42:332–336.
   PubMed Web of Science ®Google Scholar
• Kincses ZT, Veréb D, Faragó P, et al. Are migraine with and without aura really different entities? Front Neurol. 2019;10:982.
   PubMed Web of Science ®Google Scholar
• Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53:1278–1299.
   PubMed Web of Science ®Google Scholar
• Buse DC, Manack A, Serrano D, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–432.
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16:76–87.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ. Chronic migraine. BMJ. 2014;348:g1416.
   PubMed Web of Science ®Google Scholar
• Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005;18:305–310.
   PubMed Web of Science ®Google Scholar
• Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol. 2012;11:92–100.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ. The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol Clin. 2009;27:513–523.
   PubMed Web of Science ®Google Scholar
• Minen MT, Begasse De Dhaem O, Kroon Van Diest A, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87:741–749.
   PubMed Web of Science ®Google Scholar
• Rainero I, Govone F, Gai A, et al. Is migraine primarily a metaboloendocrine disorder? Curr Pain Headache Rep. 2018;22:36.
   PubMed Web of Science ®Google Scholar
• Buse DC, Silberstein SD, Manack AN, et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260:1960–1969.
   PubMed Web of Science ®Google Scholar
• Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010;11:289–299.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Fanning KM, Buse DC, et al. Identifying natural subgroups of migraine based on comorbidity and concomitant condition profiles: results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache. 2018;58:933–947.
   PubMed Web of Science ®Google Scholar
• GBD 2016. Disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1211–1259.
   PubMed Web of Science ®Google Scholar
• Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84:422–435.
   PubMed Web of Science ®Google Scholar
• Baigi K, Stewart WF. Headache and migraine: a leading cause of absenteeism. Handb Clin Neurol. 2015;131:447–463.
   PubMedGoogle Scholar
• Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the eurolight project. Eur J Neurol. 2012;19:703–711.
   PubMed Web of Science ®Google Scholar
• Gasparini CF, Sutherland HG, Griffiths LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics. 2013;14:300–315.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553–622.
   PubMed Web of Science ®Google Scholar
• Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013;154(Suppl 1):S44–53.
   PubMed Web of Science ®Google Scholar
• Brighina F, Cosentino G, Fierro B. Is lack of habituation a biomarker of migraine? A critical perspective. J Headache Pain. 2015;16:A13.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Chong CD. Functional imaging and migraine: new connections? Curr Opin Neurol. 2015;28:265–270. Aggiungere reference.
   PubMed Web of Science ®Google Scholar
• Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. J Headache Pain. 2019;20:72.
   PubMed Web of Science ®Google Scholar
• Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache. 2018;58(Suppl 1):4–16.
   PubMed Web of Science ®Google Scholar
• van Oosterhout W, van Someren E, Schoonman GG, et al. Chronotypes and circadian timing in migraine. Cephalalgia. 2017;38:617–625.
   PubMed Web of Science ®Google Scholar
• Maniyar FH, Sprenger T, Monteith T, et al. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137:232–241.
   PubMed Web of Science ®Google Scholar
• Moulton EA, Becerra L, Johnson A, et al. Altered hypothalamic functional connectivity with autonomic circuits and the locus coeruleus in migraine. PLoS One. 2014;9:e95508.
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117:199–210.
   PubMed Web of Science ®Google Scholar
• Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365–391.
   PubMed Web of Science ®Google Scholar
• Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001;81:1065–1096.
   PubMed Web of Science ®Google Scholar
• Amin FM, Hougaard A, Schytz HW, et al. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain. 2014;137:779–794.
   PubMed Web of Science ®Google Scholar
• Messlinger K, Fischer MJ, Lennerz JK. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med. 2011;60:82–89.
   PubMedGoogle Scholar
• Boyer N, Dallel R, Artola A, et al. General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression. Pain. 2014;155:1196–1205.
   PubMed Web of Science ®Google Scholar
• Kelman L. The postdrome of acute migraine attack. Cephalalgia. 2006;26:214–220.
   PubMed Web of Science ®Google Scholar
• Bose P, Goadsby PJ. The migraine postdrome. Curr Opin Neurol. 2016;29:299–301.
   PubMed Web of Science ®Google Scholar
• Montagna P. Migraine genetics. Expert Rev Neurother. 2008;8:1321–1330.
   PubMedGoogle Scholar
• Anttila V, Wessman M, Kallela M, et al. Genetics of migraine. Handb Clin Neurol. 2018;148:493–503.
   PubMedGoogle Scholar
• Mulder EJ, Van Baal C, Gaist D, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res. 2003;6:422–431.
   PubMedGoogle Scholar
• Pietrobon D. Familial hemiplegic migraine. Neurotherapeutics. 2007;4:274–284.
   PubMed Web of Science ®Google Scholar
• Svensson DA, Larsson B, Waldenlind E, et al. Shared rearing environment in migraine: results from twins reared apart and twins reared together. Headache. 2003;43:235–244.
   PubMed Web of Science ®Google Scholar
• Hiekkala ME, Vuola P, Artto V, et al. The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families. Cephalalgia. 2018;38:1849–1863.
   PubMed Web of Science ®Google Scholar
• Lebas A, Guyant-Marechal L, Hannequin D, et al. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia. 2008;28:774–777.
   PubMed Web of Science ®Google Scholar
• Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371–377.
   PubMed Web of Science ®Google Scholar
• Lafreniere RG, Cader MZ, Poulin JF, et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010;16:1157–1160.
   PubMed Web of Science ®Google Scholar
• Rainero I, Vacca A, Govone F, et al. Migraine: genetic variants and clinical phenotypes. Curr Med Chem. 2019;26:1–13.
   Google Scholar
• Kondratieva N, Azimova J, Skorobogatykh K, et al. Biomarkers of migraine: part 1 – genetic markers. J Neurol Sci. 2016;369:63–76.
   PubMed Web of Science ®Google Scholar
• Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48:856–866.
   PubMed Web of Science ®Google Scholar
• Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437:1257–1263.
   PubMed Web of Science ®Google Scholar
• Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014;24:90–99.
   PubMed Web of Science ®Google Scholar
• Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine. An electronic diary study. Neurology. 2003;60:935–940.
   PubMed Web of Science ®Google Scholar
• Alstadhaug K, Salvesen R, Bekkelund S. 24-hour distribution of migraine attacks. Headache. 2008;48:95–100.
   PubMed Web of Science ®Google Scholar
• Fox AW, Davis RL. Migraine chronobiology. Headache. 1998;38:436–441.
   PubMed Web of Science ®Google Scholar
• Tuka B, Helyes Z, Markovics A, et al. Role of PACAP in migraine headaches. Cephalalgia. 2013;33:1085–1095.
   PubMed Web of Science ®Google Scholar
• Brennan KC, Bates EA, Shapiro RE, et al. Casein kinase Idelta mutations in familial migraine and advanced sleep phase. Sci Transl Med. 2013;5:183ra56. 1-11.
   PubMed Web of Science ®Google Scholar
• Miyata A, Jiang L, Dahl RD, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun. 1990;170:643–648.
   PubMed Web of Science ®Google Scholar
• Tuka, Tuka B, Helyes Z, et al. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia. 2013;33:1085–1095.
   PubMed Web of Science ®Google Scholar
• Vaudry D, Gonzalez BJ, Basille M, et al. Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52:269–324.
   PubMed Web of Science ®Google Scholar
• Guo S, Vollesen AL, Hansen RD, et al. Part I: pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine. Cephalalgia. 2017;37:125–135.
   PubMed Web of Science ®Google Scholar
• Xu Y, Padiath QS, Shapiro RE. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 2005;434:640–644.
   PubMed Web of Science ®Google Scholar
• Gelfald A, Goadsby P. The role of melatonin in the treatment of primary headache disorders. Headache. 2016;56:1257–1266.
   PubMed Web of Science ®Google Scholar
• Peres MF, Zukerman E, da Cunha Tanuri F, et al. Melatonin 3 mg, is effective for migraine prevention. Neurology. 2004;63:757.
   PubMed Web of Science ®Google Scholar
• Do TP, Guo S, Ashina M. Therapeutic novelties in migraine: new drugs, new hope? J Headache Pain. 2019;20:37.
   PubMed Web of Science ®Google Scholar
• Kim JB. Channelopathies. Korean J Pediatr. 2014;57:1–18.
   PubMedGoogle Scholar
• Enyedi P, Czirjak G. Properties, regulation, pharmacology, and functions of the K2p channel, TRESK. Pflugers Arch. 2015;467:945–958.
   PubMed Web of Science ®Google Scholar
• Dobler T, Springauf A, Tovornik S, et al. TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurons. J Physiol. 2007;585:867–879.
   PubMed Web of Science ®Google Scholar
• Kang D, Kim D. TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons. Am J Phys Cell Physiol. 2006;2910:C138–C146.
   Google Scholar
• Liu P, Xiao Z, Ren F, et al. Functional analysis of a migraine-associated TRESK K+ channel mutation. J Neurosci. 2013;33:12810–12824.
   PubMed Web of Science ®Google Scholar
• Royal P, Andres-Bilbe A, Avalos Prado P, et al. Migraine-associated TRESK mutations increase neuronal excitability through alternative translation initiation and inhibition of TREK. Neuron. 2019;101:232–245.
   PubMed Web of Science ®Google Scholar
• Anttila V, Stefansson H, Kallela M, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22. Nat Genet. 2010;42:869–873.
   PubMed Web of Science ®Google Scholar
• Chasman DI, Schurks M, Anttila V, et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet. 2011;43:695–698.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wu M, Zubcevic L, et al. Structure of the cold- and menthol-sensing ion channel TRPM8. Science. 2018;359:237–241.
   PubMed Web of Science ®Google Scholar
• Dussor G, Cao YQ. TRPM8 and Migraine. Headache. 2016;56:1406–1417.
   PubMed Web of Science ®Google Scholar
• Dussor G, Yan J, Xie JY, et al. Targeting TRP channels for novel migraine therapeutics. ACS Chem Neurosci. 2014;5:1085–1096.
   PubMed Web of Science ®Google Scholar
• Benemei S, Dussor G. TRP channels and migraine: recent developments and new therapeutic opportunities. Pharmaceuticals (Basel). 2019;12:54.
   Google Scholar
• Bashir A, Lipton RB, Ashina S, et al. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 2013;81:1260–1268.
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Kovac S, Kurian MA, et al. Phenotypes, genotypes, and the management of paroxysmal movement disorders. Dev Med Child Neurol. 2018;60:559–565.
   PubMed Web of Science ®Google Scholar
• Lee HY, Huang Y, Bruneau N, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012;1:2–12.
   PubMed Web of Science ®Google Scholar
• Fruscione F, Valente P, Sterlini B, et al. PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity. Brain. 2018;141:1000–1016.
   PubMed Web of Science ®Google Scholar
• Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology. 2012;79:2109–2114.
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Fakhari D, Saffari A, Westenberger A, et al. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138:3476–3485.
   PubMed Web of Science ®Google Scholar
• Valente P, Castroflorio E, Rossi P, et al. PRRT2 is a key component of the Ca2+-dependent neurotransmitter release machinery. Cell Rep. 2016;15:117–131.
   PubMed Web of Science ®Google Scholar
• Shen Y, Lee HY, Rawson J, et al. Mutations in PNKD causing paroxysmal dyskinesia alter protein cleavage and stability. Human Mol Gen. 2011;20:2322–2332.
   PubMed Web of Science ®Google Scholar
• Shen Y, Ge WP, Li Y, et al. Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis. Proc Natl Acad Sci USA. 2015;112:2935–2941.
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14:65–80.
   PubMed Web of Science ®Google Scholar
• Dale RC, Gardiner A, Branson JA, et al. Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation. Dev Med Child Neurol. 2014;56:910.
   PubMed Web of Science ®Google Scholar
• van den Maagdenberg AMJM, Nyholt DR, Anttila V. Novel hypotheses emerging from GWAS in migraine? J Headache Pain. 2019;20:5.
   PubMed Web of Science ®Google Scholar
• Iljazi A, Ayata C, Ashina M, et al. The role of endothelin in the pathophysiology of migraine-a systematic review. Curr Pain Headache Rep. 2018;22:27.
   PubMed Web of Science ®Google Scholar
• Pollock DM. Dissecting the complex physiology of endothelin: new lessons from genetic models. Hypertension. 2010;56:31–33.
   PubMed Web of Science ®Google Scholar
• Nelson N. Metal ion transporters and homeostasis. Embo J. 1999;18:436–471.
   Web of Science ®Google Scholar
• McAllister BB, Dyck RH. Zinc transporter 3 (ZnT3) and vesicular zinc in central nervous system function. Neurosci Biobehav Rev. 2017;80:329–350.
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Lowe MJ, Beall E, et al. Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI. Headache. 2012;52:236–243.
   PubMed Web of Science ®Google Scholar
• McCarthy LC, Hosford DA, Riley JH, et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics. 2001;78:135–149.
   PubMed Web of Science ®Google Scholar
• Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia. 2005;25:593–597.
   PubMed Web of Science ®Google Scholar
• Lisicki M, D’Ostilio K, Coppola G, et al. Evidence of an increased neuronal activation-to-resting glucose uptake ratio in the visual cortex of migraine patients: a study comparing 18FDG-PET and visual evoked potentials. J Headache Pain. 2018;19:49.
   PubMed Web of Science ®Google Scholar
• Lee J, Pilch PF. The insulin receptor: structure, function, and signaling. Am J Physiol. 1994;266:319–334.
   PubMed Web of Science ®Google Scholar
• Gras D, Roze E, Caillet S, et al. GLUT1 deficiency syndrome: an update. Rev Neurol (Paris). 2014;170:91–99.
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Sukhotinsky I, Eikermann-Haerter K, et al. Glucose modulation of spreading depression susceptibility. J Cereb Blood Flow Metab. 2013 Feb;33:191–195.
   PubMed Web of Science ®Google Scholar